Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
ChEMBL ligand: CHEMBL526 (Diprivan, Disoprivan, Disoprofol, Fresofol, ICI 35,868, ICI 35-868, ICI-35868, ICI35,868, Lipuro, NSC-5105, Phenol, 2,6-bis(1-methylethyl), Propofol, Rapinovet) |
---|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
---|---|---|---|---|---|---|---|---|
Fatty acid amide hydrolase/Anandamide amidohydrolase in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2243] [GtoPdb: 1400] [UniProtKB: O00519] | ||||||||
ChEMBL | Inhibitory concentration against fatty acid amide hydrolase | B | 4.28 | pIC50 | 52000 | nM | IC50 | J Med Chem (2005) 48: 5059-5087 [PMID:16078824] |
Fatty acid amide hydrolase/Anandamide amidohydrolase in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3229] [GtoPdb: 1400] [UniProtKB: P97612] | ||||||||
ChEMBL | Inhibition of rat FAAH | B | 4.85 | pIC50 | 14000 | nM | IC50 | J Med Chem (2008) 51: 7327-7343 [PMID:18983142] |
Arachidonate 15-lipoxygenase in Rabbit (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4358] [UniProtKB: P12530] | ||||||||
ChEMBL | DRUGMATRIX: Lipoxygenase 15-LO enzyme inhibition (substrate: Linoleic acid) | B | 5.12 | pIC50 | 7596 | nM | IC50 | DrugMatrix in vitro pharmacology data |
carbonic anhydrase 1/Carbonic anhydrase I in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL261] [GtoPdb: 2597] [UniProtKB: P00915] | ||||||||
ChEMBL | Inhibition of human erythrocyte CA1 esterase activity using 4-nitrophenyl acetate substrate | B | 4 | pKi | 98900 | nM | Ki | Bioorg Med Chem (2009) 17: 3207-3211 [PMID:19231207] |
carbonic anhydrase 2/Carbonic anhydrase II in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL205] [GtoPdb: 3092] [UniProtKB: P00918] | ||||||||
ChEMBL | Inhibition of human erythrocyte CA2 esterase activity using 4-nitrophenyl acetate substrate | B | 4.71 | pKi | 19500 | nM | Ki | Bioorg Med Chem (2009) 17: 3207-3211 [PMID:19231207] |
COX-1 /Cyclooxygenase-1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL221] [GtoPdb: 1375] [UniProtKB: P23219] | ||||||||
ChEMBL | DRUGMATRIX: Cyclooxygenase COX-1 enzyme inhibition (substrate: Arachidonic acid) | B | 5.42 | pIC50 | 3832 | nM | IC50 | DrugMatrix in vitro pharmacology data |
GABAA receptor α1 subunit/GABAA receptor β1 subunit/GABAA receptor β3 subunit/GABAA receptor α5 subunit/GABAA receptor α3 subunit/GABAA receptor α2 subunit/GABAA receptor β2 subunit/GABAA receptor α4 subunit/GABAA receptor α6 subunit/GABA-A receptor; agonist GABA site in Human (target type: PROTEIN COMPLEX GROUP) [ChEMBL: CHEMBL2109244] [GtoPdb: 404, 410, 412, 408, 406, 405, 411, 407, 409] [UniProtKB: P14867, P18505, P28472, P31644, P34903, P47869, P47870, P48169, Q16445] | ||||||||
ChEMBL | Agonist activity at human alpha1beta2gamma2L GABAA receptor expressed in Xenopus oocytes assessed as potentiation of channel current response by two-electrode voltage clamp electrophysiology assay | F | 4.3 | pEC50 | 50000 | nM | EC50 | J Med Chem (2011) 54: 8124-8135 [PMID:22029276] |
ChEMBL | Agonist activity at human alpha1beta2gamma2L GABAA receptor expressed in Xenopus oocytes assessed as potentiation of GABA-induced current response by two-electrode voltage clamp electrophysiology assay | F | 5.28 | pEC50 | 5200 | nM | EC50 | J Med Chem (2011) 54: 8124-8135 [PMID:22029276] |
GABAA receptor α1 subunit/GABAA receptor β1 subunit/GABAA receptor γ2 subunit/GABA A receptor alpha-1/beta-1/gamma-2 in Human (target type: PROTEIN COMPLEX) [ChEMBL: CHEMBL2111392] [GtoPdb: 404, 410, 414] [UniProtKB: P14867, P18505, P18507] | ||||||||
ChEMBL | Direct activation of chloride current in Xenopus laevis oocytes expressing human alpha-1-beta-1-gamma-2 GABA-A receptor subunits | F | 4.36 | pEC50 | 44000 | nM | EC50 | J Med Chem (1998) 41: 1846-1854 [PMID:9599235] |
ChEMBL | Modulation of GABA-induced chloride currents in Xenopus laevis oocytes expressing human alpha-1-beta-1-gamma-2 GABA-A receptor subunits | F | 5.1 | pEC50 | 8000 | nM | EC50 | J Med Chem (1998) 41: 1846-1854 [PMID:9599235] |
GABAA receptor α1 subunit/GABAA receptor γ2 subunit/GABAA receptor β2 subunit/GABA-A receptor; alpha-1/beta-2/gamma-2 in Human (target type: PROTEIN COMPLEX) [ChEMBL: CHEMBL2095172] [GtoPdb: 404, 414, 411] [UniProtKB: P14867, P18507, P47870] | ||||||||
ChEMBL | Direct activation of human Gamma-aminobutyric acid A receptor alpha-1-beta-2-gamma-2 | B | 5 | pEC50 | 10000 | nM | EC50 | J Med Chem (2002) 45: 3210-3221 [PMID:12109905] |
ChEMBL | Potentiation of GABA responses at human Gamma-aminobutyric acid A receptor alpha-1-beta-2-gamma-2 | B | 5.7 | pEC50 | 1995.26 | nM | EC50 | J Med Chem (2002) 45: 3210-3221 [PMID:12109905] |
GABAA receptor α1 subunit/GABAA receptor γ2 subunit/GABAA receptor β3 subunit/GABA-A receptor; alpha-1/beta-3/gamma-2 in Human (target type: PROTEIN COMPLEX) [ChEMBL: CHEMBL2094121] [GtoPdb: 404, 414, 412] [UniProtKB: P14867, P18507, P28472] | ||||||||
ChEMBL | Inhibition of [3H]R-mTFD-MPAB labelling of GABAA alpha1beta3gamma2L (unknown origin) expressed in Xenopus laevis oocytes assessed as reduction in photoincorporation at M227 residues of beta3 subunit measured after 30 mins in presence of GABA by liquid scintillation counting method | B | 4.36 | pIC50 | 44000 | nM | IC50 | Eur J Med Chem (2020) 194: 112261-112261 [PMID:32247113] |
ChEMBL | Inhibition of [3H]pTFD-di-iPr-BnOH labelling of GABAA alpha1beta3gamma2L (unknown origin) expressed in Xenopus laevis oocytes assessed as reduction in photoincorporation at beta subunit measured after 30 mins in presence of GABA by liquid scintillation counting method | B | 4.49 | pIC50 | 32000 | nM | IC50 | Eur J Med Chem (2020) 194: 112261-112261 [PMID:32247113] |
ChEMBL | Inhibition of [3H]azietomidate labelling of GABAA alpha1beta3gamma2L (unknown origin) expressed in Xenopus laevis oocytes assessed as reduction in photoincorporation at M236 residues of alpha1 subunit measured after 30 mins in presence of GABA by liquid scintillation counting method | B | 5.1 | pIC50 | 8000 | nM | IC50 | Eur J Med Chem (2020) 194: 112261-112261 [PMID:32247113] |
ChEMBL | GABA-mimetic action on Oocytes expressing human alpha-1-beta-3-gamma-2L GABA-A receptor subunits at >=100 uM | B | 4.3 | pEC50 | 50000 | nM | EC50 | J Med Chem (2001) 44: 3582-3591 [PMID:11606122] |
ChEMBL | Positive allosteric modulation of GABAA alpha1beta3gamma2L in HEK cell plasma membrane assessed as increase in [3H]muscimol binding measured after 10 mins by liquid scintillation counting method | B | 5.27 | pEC50 | 5400 | nM | EC50 | Eur J Med Chem (2020) 194: 112261-112261 [PMID:32247113] |
ChEMBL |
GABA-modulatory action compound was evaluated on Oocytes expressing recombinant human alpha-1-beta-3-gamma-2L GABA A receptor at concentrations of >=100 micro
B
|
5.39
|
pEC50
|
4100
|
nM
|
EC50
|
J Med Chem (2001) 44: 3582-3591 [PMID:11606122]
|
|
GABAA receptor γ2 subunit/GABAA receptor α2 subunit/GABAA receptor β2 subunit/GABA A receptor alpha-2/beta-2/gamma-2 in Human (target type: PROTEIN COMPLEX) [ChEMBL: CHEMBL2111413] [GtoPdb: 414, 405, 411] [UniProtKB: P18507, P47869, P47870] | ||||||||
ChEMBL | Effective concentration against GABA-evoked chloride currents mediated by human Gamma-aminobutyric acid GABA-A receptor alpha2-beta2-gamma2L expressed in Xenopus oocytes | B | 4.95 | pEC50 | 11200 | nM | EC50 | J Med Chem (2005) 48: 2638-2645 [PMID:15801854] |
GABAA receptor π subunit/GABAA receptor β1 subunit/GABAA receptor δ subunit/GABAA receptor γ2 subunit/GABAA receptor α5 subunit/GABAA receptor α3 subunit/GABAA receptor γ1 subunit/GABAA receptor α2 subunit/GABAA receptor α4 subunit/GABAA receptor γ3 subunit/GABAA receptor α6 subunit/GABAA receptor α1 subunit/GABAA receptor β3 subunit/GABAA receptor β2 subunit/GABAA receptor ε subunit/GABA-A receptor; anion channel in Rat (target type: PROTEIN COMPLEX GROUP) [ChEMBL: CHEMBL1907607] [GtoPdb: 419, 410, 416, 414, 408, 406, 413, 405, 407, 415, 409, 404, 412, 411, 417] [UniProtKB: O09028, P15431, P18506, P18508, P19969, P20236, P23574, P23576, P28471, P28473, P30191, P62813, P63079, P63138, Q91ZM7, Q9ES14] | ||||||||
ChEMBL | Inhibition of [35S]TBPS binding to Gamma-aminobutyric acid A receptor of rat brain membranes | B | 4.74 | pIC50 | 18000 | nM | IC50 | Bioorg Med Chem Lett (2001) 11: 927-930 [PMID:11294393] |
ChEMBL | In vitro inhibition of [35S]-TBPS binding to GABA-A receptor in rat whole brain membranes | B | 4.74 | pIC50 | 18000 | nM | IC50 | Bioorg Med Chem Lett (2003) 13: 1107-1110 [PMID:12643922] |
ChEMBL | The concentration required to inhibit 50% of binding of [35S]TBPS to Gamma-aminobutyric acid A receptor to rat whole brain membranes. | B | 5.08 | pIC50 | 8300 | nM | IC50 | J Med Chem (1997) 40: 1668-1681 [PMID:9171876] |
ChEMBL | Inhibition of [35S]TBPS binding to GABA-A receptor rat whole brain membranes | B | 5.09 | pIC50 | 8100 | nM | IC50 | Bioorg Med Chem Lett (2003) 13: 1971-1975 [PMID:12781176] |
ChEMBL | Inhibition of [35S]TBPS binding to GABA-A receptor in rat cerebral cortex. | B | 5.4 | pIC50 | 3950 | nM | IC50 | J Med Chem (1998) 41: 1846-1854 [PMID:9599235] |
NET/Norepinephrine transporter in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL222] [GtoPdb: 926] [UniProtKB: P23975] | ||||||||
ChEMBL | DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55) | B | 5.03 | pKi | 9316 | nM | Ki | DrugMatrix in vitro pharmacology data |
ChEMBL | DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55) | B | 5.03 | pIC50 | 9393 | nM | IC50 | DrugMatrix in vitro pharmacology data |
5-HT2B receptor/Serotonin 2b (5-HT2b) receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1833] [GtoPdb: 7] [UniProtKB: P41595] | ||||||||
ChEMBL | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide) | B | 5.46 | pKi | 3499 | nM | Ki | DrugMatrix in vitro pharmacology data |
ChEMBL | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide) | B | 5.26 | pIC50 | 5499 | nM | IC50 | DrugMatrix in vitro pharmacology data |
5-HT2C receptor/Serotonin 2c (5-HT2c) receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL225] [GtoPdb: 8] [UniProtKB: P28335] | ||||||||
ChEMBL | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine) | B | 5.22 | pKi | 6051 | nM | Ki | DrugMatrix in vitro pharmacology data |
ChEMBL | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine) | B | 4.94 | pIC50 | 11553 | nM | IC50 | DrugMatrix in vitro pharmacology data |
TRPV1/Vanilloid receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4794] [GtoPdb: 507] [UniProtKB: Q8NER1] | ||||||||
ChEMBL | Inhibition of TRPV1 (unknown origin) | B | 8.3 | pIC50 | 5.05 | nM | IC50 | Eur J Med Chem (2023) 245: 114893-114893 [PMID:36395649] |
HCN1 in Mouse [GtoPdb: 400] [UniProtKB: O88704] | ||||||||
GtoPdb | - | - | 5.2 | pIC50 | - | - | - |
J Pharmacol Exp Ther (2005) 315: 517-25 [PMID:16033909]; J Physiol (Lond.) (2007) 583: 37-56 [PMID:17569731] |
TRPV4 in Human [GtoPdb: 510] [UniProtKB: Q9HBA0] | ||||||||
GtoPdb | - | - | 4.41 | pIC50 | 39100 | nM | IC50 | Front Pharmacol (2019) 10: 1150 [PMID:31636563] |
ChEMBL data shown on this page come from version 34:
Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]